Sandbox

Risk calculator for cholesterol appears flawed by Gina Kolata, New York Times, 17 November 2013

The article links to the following graphic summarizing the findings

For distressing commentary on a related story, see the post The Economics & Politics of Drugs for Mild Hypertension from HealthNewsReview.org (4 November 2013), which begins

The Cochrane Collaboration’s Hypertension Group published a systematic review of drug treatment for mild hypertension in August 2012 showing no evidence that drugs benefit patients while about 11% have side effects severe enough to stop treatment. As coauthor of that review, I will comment on the economics, politics, regulatory intrigue, financial conflicts, and subsequent media coverage involved.

Submitted by Paul Alper